drugset / Trial / NCT00362921

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00362921

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as Gliadel wafer and O6-benzylguanine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving Gliadel wafer together with O6-benzylguanine works in treating patients with recurrent glioblastoma multiforme.

Timeline

Start
2004-04
Primary completion
2007-08
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject O6-benzylguanine Small molecule 30 mg/m2 Other
Subject carmustine Small molecule Other

Indications